12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
MYSTERIOUS: Annovis bio - What They Never Told You
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga ·
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
The European Commission (EC) has granted conditional marketing authorization (CMA) to BioMarin Pharmaceutical’s (NASDAQ:BMRN) lead asset ROCTAVIAN (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A (congenital Factor VIII deficiency) in adult patients. BioMarin shares traded as high as 2.28 percent, in a range of $91.39 to $93.68…
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Organisations
Nasdaq
22,822 stories
NYSE
19,906 stories
FDA
7,744 stories
European Commission
2,365 stories
JP Morgan
755 stories
Piper Sandler
428 stories
Needham
423 stories
Raymond James
286 stories
B of A Securities
173 stories
Carmax
123 stories
KeyCorp
83 stories
Evercore ISI Group
73 stories
US Food and Drug Administration
63 stories
Comerica
51 stories
HC Wainwright & Co
50 stories
Weyerhaeuser
47 stories
Arthur J Gallagher
31 stories
Rhythm Pharmaceuticals
30 stories
Mohawk Industries
29 stories
Accolade
25 stories
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Topics
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
